Merck and Moderna released detailed results on an experimental vaccine to treat the skin cancer.
Back to Lifestyle
Lifestyle
October 22, 2026 at 8:01 PM
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
New York Times Well
Excerpt from New York Times Well.